Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02601794 · ClinicalTrials.gov registry record · NA

A Study of Delivering a Mindfulness App Intervention to Accompany Supportive Care Among Women With Breast Cancer

A NA study of Breast Cancer, sponsored by The University of Texas Health Science Center at San Antonio.

Completed
Registry status
NA
Development phase
112
Enrollment target
1
Study location

NCT02601794 is a NA study of Breast Cancer that has completed, run by The University of Texas Health Science Center at San Antonio. The registered enrollment target is 112 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02601794, a NA study of Breast Cancer, has completed, sponsored by The University of Texas Health Science Center at San Antonio.

COMPLETED
Registry status
NA
Development phase
112 participants
Enrollment target
1
Study location

Study Summary

The investigators are conducting a web-based study to explore the use of a mindfulness app to improve quality of life among women with breast cancer. Eligible participants will be asked to provide informed consent to participate and submit a data authorization form to obtain information from the app at the end of the project. This 12-week project will randomly assign participants to one of two groups: Group 1 (AMT) will receive the mindfulness app right away; Group 2 (WC) will receive the mindfulness app at the end of 12 weeks. All participants will receive a welcome email with group designation. Participants assigned to Group 1 (AMT) will also receive app download instructions and pass code. Group 1 will be asked to complete the app's first 10-minute mindfulness exercise, at minimum. Participants assigned to Group 2 (WC) will be notified that they will receive app download instructions and pass code at the end of 12 weeks. Regardless of group assignment, all participants will be asked to complete web-based survey assessments 4 different times throughout the study (baseline, week 5, week 9, 12-week follow up). The surveys will be related to quality of life, mindfulness, mobile technology, health literacy, and chronic pain. To encourage participation, a member of the study team will send out weekly check-in emails. Once all data has been collected, app developers will provide the investigators with app data for each participant, including times accessed, length of time using app. This information will help the investigators observe which app characteristics are most useful, as well as the optimal amount of time needed to obtain benefit from the app. The investigators goals are to understand how using the mindfulness app compares to not using the mindfulness app. The investigators will also observe whether the app contributes to participants' quality of life. The investigators also want to understand more about how women use health apps overall. This informat

Conditions Studied

Interventions

  • BEHAVIORAL App-based Mindfulness Training

Study Locations (1)

Texas

  • University of Texas Health Science Center San Antonio - San Antonio

Trial Details

FieldValue
Enrollment Target 112 participants
Start Date 2015-08
Est. Completion 2016-06
Phase NA

What the Registry Record Tells You About NCT02601794

The ClinicalTrials.gov registry entry for NCT02601794 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 112 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (96% lower). The listed sponsor is The University of Texas Health Science Center at San Antonio, which has 378 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which App-based Mindfulness Training is the first listed.

NCT02601794 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT02601794 about?

NCT02601794 is a clinical study titled "A Study of Delivering a Mindfulness App Intervention to Accompany Supportive Care Among Women With Breast Cancer". The investigators are conducting a web-based study to explore the use of a mindfulness app to improve quality of life among women with breast cancer. Eligible participants will be asked to provide informed consent to participate and submit a data authorization form to obtain information from the ap...

What is the current status of trial NCT02601794?

This trial is currently completed. It is a NA study. The enrollment target is 112 participants. The study started on 2015-08. Estimated completion is 2016-06.

What conditions does trial NCT02601794 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT02601794?

The interventions under investigation include: App-based Mindfulness Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT02601794?

This trial is sponsored by The University of Texas Health Science Center at San Antonio, which has 378 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02601794 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.